Publications by authors named "Thomas R Zimmerman"


Twelve-month, open-label assessment of long-term safety and abuse potential of hydrocodone extended-release formulated with abuse-deterrence technology in patients with chronic pain.

J Opioid Manag 2015 Sep-Oct;11(5):425-34

Vice President, Global Clinical Development, Pain Therapeutic Area Head, Teva Pharmaceuticals, Frazer, Pennsylvania.

View Article

Download full-text PDF

Source Listing
February 2016